| scholarly article | Q13442814 |
| P50 | author | Gilberto de Nucci | Q5561420 |
| Marcelo N. Muscara | Q47504443 | ||
| Edson Antunes | Q56686201 | ||
| Angelina Zanesco | Q61784604 | ||
| P2093 | author name string | F Z T Mónica | |
| C S Porto | |||
| S A Teixeira | |||
| F M F Abdalla | |||
| A A O Bricola | |||
| F R Báu | |||
| L L Lopes Freitas | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study | Q28202479 | ||
| Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo | Q28379545 | ||
| Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype | Q28591691 | ||
| Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder | Q33539504 | ||
| Nitric oxide and the proliferation of vascular smooth muscle cells | Q33847601 | ||
| Urinary bladder contraction and relaxation: physiology and pathophysiology | Q34335220 | ||
| Prevalence and burden of overactive bladder in the United States | Q34534593 | ||
| Species differences in the distribution of beta-adrenoceptor subtypes in bladder smooth muscle | Q35027616 | ||
| Muscarinic receptor subtypes and management of the overactive bladder | Q35031220 | ||
| Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta | Q35041493 | ||
| Mechanisms of beta 3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium | Q35048451 | ||
| Nitric oxide and the lower urinary tract: current concepts, future prospects. | Q35155888 | ||
| Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate | Q35545711 | ||
| Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder | Q35546189 | ||
| Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. | Q35751759 | ||
| Effects of inhibition of the L-arginine/nitric oxide pathway in the rat lower urinary tract in vivo and in vitro | Q35870798 | ||
| Calcium events in smooth muscles and their interstitial cells; physiological roles of sparks | Q36272888 | ||
| Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: A systematic review | Q36576184 | ||
| The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. | Q37385274 | ||
| Activation of alpha 1-adrenoceptors increases [3H]inositol metabolism in rat vas deferens and caudal artery | Q41898421 | ||
| Chronic nitric oxide inhibition model six years on. | Q42087123 | ||
| Pharmacological characterization of beta-adrenoceptors mediating relaxation of the rat urinary bladder in vitro | Q43194368 | ||
| Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension | Q43420596 | ||
| Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder | Q43601081 | ||
| Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. | Q44132595 | ||
| Relationship of mass of obstructed rat bladders and responsiveness to adrenergic stimulation | Q44156959 | ||
| Different distribution of nitric oxide synthase and soluble guanylyl cyclase activities in the detrusor and proximal urethra of the rabbit | Q44190433 | ||
| Activity and expression of nitric oxide synthase in the hypertrophied rat bladder and the effect of nitric oxide on bladder smooth muscle growth | Q44222832 | ||
| Upregulation of muscarinic receptors by long-term nitric oxide inhibition in the rat ileum. | Q44326264 | ||
| Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction | Q44357454 | ||
| A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders | Q44508678 | ||
| The M2 muscarinic receptor mediates contraction through indirect mechanisms in mouse urinary bladder | Q44515675 | ||
| Regional difference in functional roles of cAMP and cGMP in lower urinary tract smooth muscle contractility | Q44855670 | ||
| Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. | Q45012617 | ||
| Cystometric findings in mice lacking muscarinic M2 or M3 receptors | Q45147269 | ||
| Demonstration of bladder selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder | Q45148627 | ||
| Advantages for transdermal over oral oxybutynin to treat overactive bladder: Muscarinic receptor binding, plasma drug concentration, and salivary secretion | Q46799844 | ||
| Purification of insoluble nitric oxide synthase from rat cerebellum | Q48488531 | ||
| Overactive bladder: prevalence and implications in Brazil. | Q48511621 | ||
| Effects of gender, age and hypertension on beta-adrenergic receptor function in rat urinary bladder. | Q51802425 | ||
| Human Idiopathic and Neurogenic Overactive Bladders and the Role of M2 Muscarinic Receptors in Contraction | Q61613696 | ||
| Bladder instability and denervation in patients with bladder outflow obstruction | Q68532884 | ||
| The inositol phosphate/diacylglycerol pathway in MA-10 Leydig tumor cells. Activation by arginine vasopressin and lack of effect of epidermal growth factor and human choriogonadotropin | Q69737581 | ||
| Co-existence of nitrergic, peptidergic and acetylcholine esterase-positive nerves in the pig lower urinary tract | Q71893325 | ||
| Physiological and morphometric studies into the pathophysiology of detrusor hyperreflexia in neuropathic patients | Q72151904 | ||
| Long-term nitric oxide inhibition and chronotropic responses in rat isolated right atria | Q73087502 | ||
| Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans | Q73321320 | ||
| Effect of estrogen on intracellular signaling pathways linked to activation of M(2)- and M(3)-muscarinic acetylcholine receptors in the rat myometrium | Q73544814 | ||
| Escherichia coli-induced inducible nitric oxide synthase and cyclooxygenase expression in the mouse bladder and kidney | Q73569333 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1659-1668 | |
| P577 | publication date | 2008-02-25 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity | |
| P478 | volume | 153 |
| Q40114581 | Administration of BAY 41-2272 prevents bladder dysfunction in nitric-oxide deficient rats |
| Q36539976 | Association of insulin resistance with overactive bladder in female patients |
| Q54583146 | Characterization of the urinary bladder dysfunction in renovascular hypertensive rats. |
| Q85853632 | Does hypercholesterolemia affect the relaxation of the detrusor smooth muscle in rats? In vitro and in vivo studies |
| Q64114052 | Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice1 |
| Q52305623 | Effects of chronic administration of tamsulosin and tadalafil, alone or in combination, in rats with bladder outlet obstruction induced by chronic nitric oxide deficiency. |
| Q33692677 | Effects of nitric oxide inhibitors in mice with bladder outlet obstruction |
| Q35025867 | Human Urinary Bladder Strip Relaxation by the β-Adrenoceptor Agonist Isoprenaline: Methodological Considerations and Effects of Gender and Age. |
| Q37018672 | Increased bladder wall thickness in diabetic and nondiabetic women with overactive bladder |
| Q51277085 | Long-term treatment with the beta-3 adrenoceptor agonist, mirabegron ameliorates detrusor overactivity and restores cyclic adenosine monophosphate (cAMP) levels in obese mice. |
| Q90116976 | NO-releasing nanoparticles ameliorate detrusor overactivity in transgenic sickle cell mice via restored NO/ROCK signaling |
| Q37481272 | Preclinical compounds for the treatment of overactive bladder. |
| Q48508163 | Proteomic analysis of urothelium of rats with detrusor overactivity induced by bladder outlet obstruction. |
| Q47603923 | Stimulators and activators of soluble guanylate cyclase for urogenital disorders |
| Q44439706 | Urothelium-dependent and urothelium-independent detrusor contractility mediated by nitric oxide synthase and cyclooxygenase inhibition |
| Q48112211 | cAMP-dependent regulation of RhoA/Rho-kinase attenuates detrusor overactivity in a novel mouse experimental model. |
Search more.